North Chicago Business
-
Abbvie raises annual earnings guidance as Humira sales surgeOct 31, 2014 1:01 am - North Chicago-based AbbVie Inc., which abandoned a $52 billion deal with Shire Plc. last week after changes to U.S. tax rules, raised its annual earnings guidance after ...
-
AbbVie calls off Shire acquisitionOct 20, 2014 1:00 am - North Chicago-based pharmaceutical company AbbVie Inc. officially called off its planned $55 billion acquisition of Irish drug manufacturer Shire plc Monday, citing chan...
-
AbbVie may drop Shire bid as tax rules change mathOct 16, 2014 1:01 am - North Chicago-based AbbVie Inc. is on the verge of abandoning its $51 billion takeover of Shire Plc after recent talks with the U.S. Treasury Department and Internal Rev...
-
Shire: AbbVie should proceed with $55B acquisitionOct 15, 2014 1:01 am - The drugmaker Shire wants North Chicago-based AbbVie to stick with its roughly $55 billion acquisition bid, and it is reminding its U.S. counterpart of the hefty breakup...
-
FDA approves AbbVie's Humira for pediactric Crohn'sSep 25, 2014 1:01 am - North Chicgo-based AbbVie announced today that the U.S. Food and Drug Administration has approved HUMIRA for reducing signs and symptoms, and achieving and maintaining c...
-
Jelly Belly production leaving North ChicagoAug 11, 2014 1:01 am - Jelly Belly jelly beans will no longer be made in the company's North Chicago factory, according to a recent workforce reduction announcement made by the company. Nearly...
-
AbbVie 2Q profit climbs 2.8 percentJul 25, 2014 1:01 am - AbbVie Inc. on Friday reported profit that increased by 2.8 percent in its second quarter, and topped analysts' expectations. The North Chicago,-based company said earni...
-
AbbVie, Shire agree on $55B combinationJul 18, 2014 1:00 am - North Chicago drugmaker AbbVie has reached a roughly $55 billion deal to combine with British counterpart Shire and become the latest U.S. company to seek an overseas ha...
-
AbbVie, Shire enter detailed talks on combinationJul 14, 2014 1:01 am - Drugmakers AbbVie, of North Chicago, and Shire are in detailed talks about a possible combination after AbbVie once again raised the deal price and gave Shire shareholde...
-
AbbVie raises its bid for Shire by about 11 pctJul 08, 2014 1:01 am - NEW YORK - U.S. drugmaker AbbVie has boosted its offer for Shire by 11 percent to about $51.3 billion, hoping it will be enough to pique the interest of its British coun...